# Efficacy and Safety Study of Seroquel SR in the Treatment of Generalised Anxiety Disorder

> **NCT00389064** · PHASE3 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 450 (actual)

## Conditions studied

- Anxiety Disorders

## Interventions

- **DRUG:** Quetiapine XR
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00389064
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-09
- **Primary completion:** 2008-04
- **Final completion:** 2008-04
- **Target enrollment:** 450 (ACTUAL)
- **Last updated:** 2012-04-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00389064

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00389064, "Efficacy and Safety Study of Seroquel SR in the Treatment of Generalised Anxiety Disorder". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00389064. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*